Linezolid-Induced Myelosuppression
Linezolid is an antibiotic effective against resistant gram-positive bacteria. While side effects are typically mild, myelosuppression can occur, with pancytopenia being a rare but serious condition. We report on a 94-year-old woman who developed pancytopenia following linezolid treatment of celluli...
Saved in:
| Main Authors: | Kristiana Jordan, Kristen D. Kelley |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-08-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0263 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linezolid and tedizolid adverse effects: a review on serotonin syndrome, myelosuppression, neuropathies, and lactic acidosis
by: Adam Greenfield, et al.
Published: (2025-01-01) -
POLYSACCHARIDES TUSSILAGOFARFARA L. REDUCE MYELOSUPPRESSION INDUCED BY CISPLATIN AND ETOPOSIDE
by: E. A. Safonova, et al.
Published: (2017-09-01) -
Linezolid-induced haematological toxicity
by: Libe Moraza, et al.
Published: (2015-11-01) -
Trilaciclib: A Novel Approach to Mitigate Chemotherapy-Induced Myelosuppression in Cancer Treatment
by: Mayank Kapoor, et al.
Published: (2024-08-01) -
The mechanisms of blood system regulation under myelosuppressive influences
by: E. D. Goldberg, et al.
Published: (2002-06-01)